Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
radiation
Questions discussed in this category
For patients with germline BRCA1/2 mutations, how do you approach the discussion about the potential risks of radiation therapy exposure and the development of secondary malignancies?
For patients with BRCA 1/2 germline mutations, how do you navigate the conversation with patients regarding the potential risks of RT exposure and sec...
1 Answer available
25493
Related Topics
Breast Cancer
Medical Oncology
BRCA+
Breast Cancer, Non-metastatic
secondary malignancy